These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38920591)

  • 41. Determination of lysophosphatidic acids by capillary electrophoresis with indirect ultraviolet detection.
    Chen YL; Xu Y
    J Chromatogr B Biomed Sci Appl; 2001 Apr; 753(2):355-63. PubMed ID: 11334351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
    Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
    Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Lysophosphatidic acid (LPA) stimulates invasion and metastatic colonization of ovarian cancer cells through Rac activation].
    Yu X; Zhang Y; Chen H
    Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):95-100. PubMed ID: 25975684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biodistribution of negatively charged iron oxide nanoparticles (IONPs) in mice and enhanced brain delivery using lysophosphatidic acid (LPA).
    Sun Z; Worden M; Thliveris JA; Hombach-Klonisch S; Klonisch T; van Lierop J; Hegmann T; Miller DW
    Nanomedicine; 2016 Oct; 12(7):1775-1784. PubMed ID: 27125435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor.
    Chou CH; Wei LH; Kuo ML; Huang YJ; Lai KP; Chen CA; Hsieh CY
    Carcinogenesis; 2005 Jan; 26(1):45-52. PubMed ID: 15471896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.
    Symowicz J; Adley BP; Woo MM; Auersperg N; Hudson LG; Stack MS
    Cancer Res; 2005 Mar; 65(6):2234-42. PubMed ID: 15781636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
    Yu X; Zhang Y; Chen H
    BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of lysophosphatidic acid receptor-2 expression by RNA interference decreases lysophosphatidic acid-induced urokinase plasminogen activator activation, cell invasion, and migration in ovarian cancer SKOV-3 cells.
    Wang GL; Wen ZQ; Xu WP; Wang ZY; Du XL; Wang F
    Croat Med J; 2008 Apr; 49(2):175-81. PubMed ID: 18461672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
    Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
    Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
    Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
    J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells.
    Mukherjee A; Wu J; Barbour S; Fang X
    J Biol Chem; 2012 Jul; 287(30):24990-5000. PubMed ID: 22665482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Malignant effusions contain lysophosphatidic acid (LPA)-like activity.
    Westermann AM; Havik E; Postma FR; Beijnen JH; Dalesio O; Moolenaar WH; Rodenhuis S
    Ann Oncol; 1998 Apr; 9(4):437-42. PubMed ID: 9636836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.
    Xu J; Lai YJ; Lin WC; Lin FT
    J Biol Chem; 2004 Mar; 279(11):10459-68. PubMed ID: 14688263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells.
    Fang X; Yu S; Bast RC; Liu S; Xu HJ; Hu SX; LaPushin R; Claret FX; Aggarwal BB; Lu Y; Mills GB
    J Biol Chem; 2004 Mar; 279(10):9653-61. PubMed ID: 14670967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A role for gelsolin in stress fiber-dependent cell contraction.
    Arora PD; Janmey PA; McCulloch CA
    Exp Cell Res; 1999 Jul; 250(1):155-67. PubMed ID: 10388529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.
    David M; Sahay D; Mege F; Descotes F; Leblanc R; Ribeiro J; Clézardin P; Peyruchaud O
    PLoS One; 2014; 9(5):e97771. PubMed ID: 24828490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lysophosphatidic Acid is a Biomarker for Peritoneal Carcinomatosis of Gastric Cancer and Correlates with Poor Prognosis.
    Zeng R; Li B; Huang J; Zhong M; Li L; Duan C; Zeng S; Huang J; Liu W; Lu J; Tang Y; Zhou L; Liu Y; Li J; He Z; Wang Q; Dai Y
    Genet Test Mol Biomarkers; 2017 Nov; 21(11):641-648. PubMed ID: 28910191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer.
    Fujita T; Miyamoto S; Onoyama I; Sonoda K; Mekada E; Nakano H
    Cancer Lett; 2003 Mar; 192(2):161-9. PubMed ID: 12668280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A chromo- and fluorogenic sensor for probing the cancer biomarker lysophosphatidic acid.
    Zhao W; Liu W; Zhang W; Zeng L; Fan Z; Wu J; Wang P
    Analyst; 2012 Apr; 137(8):1853-9. PubMed ID: 22407194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.
    Kim KS; Sengupta S; Berk M; Kwak YG; Escobar PF; Belinson J; Mok SC; Xu Y
    Cancer Res; 2006 Aug; 66(16):7983-90. PubMed ID: 16912173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.